MENU
+Compare
HAE
Stock ticker: NYSE
AS OF
Apr 1 closing price
Price
$63.02
Change
-$0.53 (-0.83%)
Capitalization
4.33B

HAE Haemonetics Corp Forecast, Technical & Fundamental Analysis

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces... Show more

HAE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for HAE with price predictions
Mar 31, 2025

HAE in downward trend: price may drop because broke its higher Bollinger Band on March 07, 2025

HAE broke above its upper Bollinger Band on March 07, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 35 similar instances where the stock broke above the upper band. In of the 35 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 17, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on HAE as a result. In of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for HAE turned negative on March 21, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HAE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HAE advanced for three days, in of 329 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 207 cases where HAE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.564) is normal, around the industry mean (23.715). P/E Ratio (34.467) is within average values for comparable stocks, (83.458). Projected Growth (PEG Ratio) (1.624) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (3.428) is also within normal values, averaging (41.612).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. HAE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HAE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
HAE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

HAE is expected to report earnings to rise 2.52% to $1.22 per share on May 13

Haemonetics Corp HAE Stock Earnings Reports
Q1'25
Est.
$1.22
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.05
Q2'24
Beat
by $0.01
Q1'24
Beat
by $0.01
The last earnings report on February 06 showed earnings per share of $1.19, beating the estimate of $1.17. With 616.72K shares outstanding, the current market capitalization sits at 4.33B.
A.I. Advisor
published General Information

General Information

a manufacturer of blood processing systems

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
125 Summer Street
Phone
+1 781 848-7100
Employees
3034
Web
https://www.haemonetics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FTXN30.280.35
+1.17%
First Trust Nasdaq Oil & Gas ETF
JMEE55.980.25
+0.45%
JPMorgan Small & Mid Cap Enh Eq ETF
QVOY24.300.08
+0.33%
Q3 All-Season Active Rotation ETF
IBMQ25.290.04
+0.16%
iShares iBonds Dec 2028 Term Muni Bd ETF
BRAZ21.68-0.13
-0.61%
Global X Brazil Active ETF

HAE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HAE has been loosely correlated with GH. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if HAE jumps, then GH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HAE
1D Price
Change %
HAE100%
+0.57%
GH - HAE
34%
Loosely correlated
-1.25%
OM - HAE
32%
Poorly correlated
-12.08%
HOLX - HAE
32%
Poorly correlated
+0.73%
ATR - HAE
31%
Poorly correlated
+0.99%
NEOG - HAE
31%
Poorly correlated
+0.35%
More